Let's say, for example, we start to use the drug in a clinical context. We recognize that there are differences in response across a population of patients, only observed once it's in the clinical context. In the process, though, we're a research hospital, we're collecting extra tissue from those patients. We analyze then, in retrospect...those tissues have different characteristics that predict for different outcomes with the application of that drug.
The next step is: who's going to make these tests as a routine activity of the use of that drug in the health care system? That iteration has to happen within the health care system. The problem is that the health care system is not really built to innovate. We've bolted the expectation on it, as demonstrated by this committee talking about this topic, but we're not actually built to innovate.